XML 62 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders’ Equity (Deficit) (Details) - Schedule of Options Activity - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Options Activity [Abstract]    
Outstanding - beginning, Amount of options 988,264 863,264
Outstanding - beginning, Weighted average exercise price $ 0.563 $ 0.614
Granted amount of options 471,500 [1] 145,000
Granted weighted average exercise price $ 1.224 $ 0.184
Exercised amount of options (4,666)
Exercised weighted average exercise price $ 0.003
Expired or forfeited amount of options (5,000) (15,334)
Expired or forfeited weighted average exercise price $ 0.664 $ 0.003
Outstanding - end, Amount of options 1,454,764 988,264
Outstanding - end, Weighted average exercise price $ 0.777 $ 0.563
Exercisable at end, Amount of options 889,125 753,236
Exercisable at end, Weighted average exercise price $ 0.612 $ 0.703
[1] Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company’s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.